Clinical Trial Update: Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of ketoconazole, hydrocortisone, and dutasteride in asymptomatic hormone-refractory prostate cancer has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• HYDROCORTISONE (HYDROCORTISONE)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-04-22